Infective and thrombotic complications of central venous catheters in patients with hematological malignancy: prospective evaluation of nontunneled devices

被引:80
|
作者
Worth, Leon J. [1 ,2 ]
Seymour, John F. [3 ]
Slavin, Monica A. [2 ]
机构
[1] Peter MacCallum Canc Ctr, Dept Infect Dis, Melbourne, Vic 3002, Australia
[2] Royal Melbourne Hosp, Ctr Clin Res Excellence Infect Dis, Victorian Infect Dis Serv, Parkville, Vic 3052, Australia
[3] Univ Melbourne, Parkville, Vic 3050, Australia
关键词
CVC-related bloodstream infection; Thrombosis; Peripherally inserted CVC; Nontunneled CVC; Hematology; Surveillance; BLOOD-STREAM INFECTIONS; NOSOCOMIAL INFECTIONS; CELL TRANSPLANTATION; BONE-MARROW; LONG-TERM; SURVEILLANCE; PREVENTION; GUIDELINES; EFFICACY; RISK;
D O I
10.1007/s00520-008-0561-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Central venous catheter (CVC)-related bloodstream infection (CR-BSI) is a significant complication in hematology patients. A range of CVC devices may be used, and risks for the development of complications are not uniform. The objectives of this study were to determine the natural history and rate of CVC-related complications and risk factors for CR-BSI and to compare device-specific complications in a hematology population. An observational cohort of patients with hematologic malignancy was prospectively studied following CVC insertion. Participants were reviewed until a CVC-related complication necessitated device removal, completion of therapy, death, or defined end-of-study date. The National Nosocomial Infection Surveillance definition for CR-BSI was used. Overall and device-specific rates of infective and noninfective complications were calculated and potential risk factors were captured. One hundred six CVCs (75 peripherally inserted central venous catheters [PICCs], 31 nontunneled CVCs) were evaluated in 66 patients, over 2,399 CVC days. Thrombosis occurred in 16 cases (15.1%), exit-site infection in two (1.9%), and CR-BSI in 18 (7.5 per 1,000 CVC days). No significant differences were found when complication rates in PICC and nontunneled devices were compared. An underlying diagnosis of acute myeloid leukemia was negatively associated with CR-BSI (odds ratio (OR) 0.14, p = 0.046), and a previous diagnosis of fungal infection was associated with infection (OR 22.82, p = 0.031). CR-BSI rates in our hematology population are comparable to prior reports. A low rate of exit-site infection and high proportion of thrombotic complications were observed. No significant differences in thrombotic or infective complications were evident when PICC and nontunneled devices were compared. PICC devices are a practical and safe option for management of hematology patients.
引用
收藏
页码:811 / 818
页数:8
相关论文
共 50 条
  • [41] Risk factors, management and primary prevention of thrombotic complications related to the use of central venous catheters
    Linnemann, Birgit
    Lindhoff-Last, Edelgard
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2012, 41 (05) : 319 - 332
  • [42] Central venous catheters in premature babies: radiological evaluation, malpositioning and complications
    Beluffi, Giampiero
    Perotti, Gianfranco
    Sileo, Chiara
    Fiori, Paola
    Figar, Tiziana
    Stronati, Mauro
    PEDIATRIC RADIOLOGY, 2012, 42 (08) : 1000 - 1008
  • [43] Central venous catheters in premature babies: radiological evaluation, malpositioning and complications
    Giampiero Beluffi
    Gianfranco Perotti
    Chiara Sileo
    Paola Fiori
    Tiziana Figar
    Mauro Stronati
    Pediatric Radiology, 2012, 42 : 1000 - 1008
  • [44] Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters
    Tran, Ha
    Arellano, Martha
    Chamsuddin, Abbas
    Flowers, Christopher
    Heffner, Leonard T.
    Langston, Amelia
    Lechowicz, Mary Jo
    Tindol, Allen
    Waller, Edmund
    Winton, Elliott F.
    Khoury, Hanna J.
    LEUKEMIA & LYMPHOMA, 2010, 51 (08) : 1473 - 1477
  • [45] Peripherally inserted central catheters can be an alternative to tunneled central venous catheters in chemotherapy for hematological and oncological pediatric patients
    Kamata, Yuko
    Mizuno, Yuki
    Okamoto, Kentaro
    Okamoto, Shota
    Ito, Yoshifumi
    Nishigata, Aya
    PEDIATRIC SURGERY INTERNATIONAL, 2023, 39 (01)
  • [46] Peripherally inserted central catheters can be an alternative to tunneled central venous catheters in chemotherapy for hematological and oncological pediatric patients
    Yuko Kamata
    Yuki Mizuno
    Kentaro Okamoto
    Shota Okamoto
    Yoshifumi Ito
    Aya Nishigata
    Pediatric Surgery International, 39
  • [47] PERIPHERALLY INSERTED CENTRAL CATHETERS CAN BE ALTERNATIVE TO TUNNELED CENTRAL VENOUS CATHETERS IN CHEMOTHERAPY FOR HEMATOLOGICAL AND ONCOLOGICAL PEDIATRIC PATIENTS
    Kamata, Yuko
    Okamoto, Kentaro
    Mizuno, Yuki
    Ito, Yoshifumi
    Nishigata, Aya
    Okamoto, Shouta
    PEDIATRIC BLOOD & CANCER, 2024, 71 : S52 - S52
  • [48] Management of Complications Related to Central Venous Catheters in Cancer Patients: An Update
    Linnemann, Birgit
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2014, 40 (03): : 382 - 394
  • [49] Catheter-Related Complications in Patients with Central Venous or Hemodialysis Catheters
    Napalkov, Pavel
    Felici, Diana
    Chu, Laura
    Jacobs, Joan
    Begelman, Susan M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S118 - S119
  • [50] Thromboembolic complications related to central venous access catheters in cancer patients
    Freytes, Cesar O.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2007, 33 (04): : 389 - 396